Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATOMIC: Sofosbuvir + PEG/RBV in HCV
NCT01329978Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Mar 2011
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sofosbuvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Mar 2011; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01329978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01329978.